The Latest Breaking News on Pharma

The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

On Jan. 3, the U.S. Food and Drug Administration took a first step toward making abortion pills available at retail pharmacies. It released new rules outlining how both bricks-and-mortar and mail-order pharmacies can get certified to dispense mifepristone, the first pill in a medication abortion. But the agency also left…

The company agrees to settle more than 870 suits alleging that its Willowbrook plant released ethylene oxide gas. Last year, a jury awarded a cancer survivor $363 million.

Several antibiotics used to treat infections in children are in short supply, sparking concerns among doctors and pharmacists.

Overseas supply issues are leading to a shortage in some antibiotic medications used to treat illnesses such as pneumonia and strep throat.

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.

Derek Dragsnes manufactured the drug etizolam at an industrial unit in North Lanarkshire.

Despite various macroeconomic headwinds, the healthcare industry is well-positioned to cope well due to the inelastic demand for products and services. Moreover, expanding R&D initiatives and favorable government funding should accelerate the industry's growth. Therefore, fundamentally sound medical stocks Premier Inc. (PINC) could be a wise addition to one's portfolio.…